Gender Differences in P-Glycoprotein Expression and Function: Effects on Drug Disposition and Outcome

被引:58
作者
Bebawy, M. [1 ]
Chetty, M. [1 ]
机构
[1] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia
关键词
P-glycoprotein; gender differences; cytochrome P450; drug disposition; male; female; therapeutic outcome; SEX-RELATED DIFFERENCES; HUMAN-IMMUNODEFICIENCY-VIRUS; BLOOD-BRAIN-BARRIER; MULTIDRUG-RESISTANCE; HUMAN LIVER; STEROID-HORMONES; CYTOCHROME-P450; 3A; IN-VITRO; TISSUE DISTRIBUTION; DYNAMIC INTERPLAY;
D O I
10.2174/138920009788498996
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Gender differences in drug concentrations, drug response and toxicity have been attributed to various distinct yet interrelated physiological and molecular mechanisms. Drug transporters and metabolising enzymes play an important role in the xenobiotic cascade and are important regulators of drug disposition at the molecular level. The proposal of a dynamic interplay between drug metabolism and efflux has positioned drug transporters as important mediators of gender disparity in respect to drug disposition and therapeutic response. In examining the effects of gender on drug disposition and response we will specifically direct our focus on the role of the predominant drug transporter, P-glycoprotein. This review focuses on the role of the P-glycoprotein as a molecular mediator of gender differences in both drug exposure and response. Differences in transporter expression and function will be discussed together with the molecular basis for the observed difference in drug exposure between the sexes. Gender differences affecting transporter expression and function at the effect compartment and the effect of this on drug response will also be discussed.
引用
收藏
页码:322 / 328
页数:7
相关论文
共 89 条
  • [1] Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver
    Albermann, N
    Schmitz-Winnenthal, FH
    Z'graggen, K
    Volk, C
    Hoffmann, MM
    Haefeli, WE
    Weiss, J
    [J]. BIOCHEMICAL PHARMACOLOGY, 2005, 70 (06) : 949 - 958
  • [2] Tissue distribution and ontogeny of sulfotransferase enzymes in mice
    Alnouti, Yazen
    Klaassen, Curtis D.
    [J]. TOXICOLOGICAL SCIENCES, 2006, 93 (02) : 242 - 255
  • [3] ALTUVIA S, 1993, J BIOL CHEM, V268, P27127
  • [4] Gender differences in pharmacological response
    Anderson, Gail D.
    [J]. EPILEPSY IN WOMEN: THE SCIENTIFIC BASIS FOR CLINICAL MANAGEMENT, 2008, 83 : 1 - 10
  • [5] THE GENE ENCODING MULTIDRUG RESISTANCE IS INDUCED AND EXPRESSED AT HIGH-LEVELS DURING PREGNANCY IN THE SECRETORY EPITHELIUM OF THE UTERUS
    ARCECI, RJ
    CROOP, JM
    HORWITZ, SB
    HOUSMAN, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (12) : 4350 - 4354
  • [6] AXIOTIS CA, 1991, LAB INVEST, V65, P577
  • [7] Selective modulation of P-glycoprotein-mediated drug resistance
    Bebawy, M
    Morris, MB
    Roufogalis, BD
    [J]. BRITISH JOURNAL OF CANCER, 2001, 85 (12) : 1998 - 2003
  • [8] Differential pharmacological regulation of drug efflux and pharmacoresistant schizophrenia
    Bebawy, Mary
    Chetty, Manoranjenni
    [J]. BIOESSAYS, 2008, 30 (02) : 183 - 188
  • [9] Unmasking the dynamic interplay between efflux transporters and metabolic enzymes
    Benet, LZ
    Cummins, CL
    Wu, CY
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 277 (1-2) : 3 - 9
  • [10] Transporter-enzyme interactions:: Implications for predicting drug-drug interactions from in vitro data
    Benet, LZ
    Cummins, CL
    Wu, CY
    [J]. CURRENT DRUG METABOLISM, 2003, 4 (05) : 393 - 398